Clinical Trials Directory

Trials / Completed

CompletedNCT04414306

Screen to Save 2: Rural Cancer Screening Educational Intervention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
205 (actual)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to help the Dartmouth Cancer Center and the National Cancer Institute understand how to educate people about cancer screening.

Detailed description

The Dartmouth Cancer Center's Community Outreach and Engagement Team will implement Screen to Save 2 using an online format. The education will be based on a set of key messages that cover information about colorectal cancer, including risk factors, prevention, screening recommendations, and screening options. Key messages provided by the National Cancer Institute will be tailored to the local context of NH and VT, including information about local options for getting screened for colorectal cancer. Using online or telephone surveys, some participants will be contacted approximately three months after their initial participation. Some of the participants contacted after three months will again be contacted another three months later (six months after initial participation). The three- and six-month surveys will assess knowledge, attitudes, beliefs, and behaviors related to cancer screening, including outcomes from cancer screening. The primary aim of the study is to implement and evaluate Screen to Save 2 outreach and educational activities to improve knowledge of colorectal cancer screening methods, to increase intent to get screened for colorectal cancer, and connect screening services to the target population.

Conditions

Interventions

TypeNameDescription
OTHEROnline educational video and website moduleParticipants will receive online education via a video and website. Key messages will include information on risk factors, prevention, screening recommendations, and screening options pertaining to colorectal cancer. Some participants will be asked to participate in three and/or six-month follow-up surveys administered online or by telephone.

Timeline

Start date
2020-10-08
Primary completion
2023-11-30
Completion
2023-11-30
First posted
2020-06-04
Last updated
2026-02-02
Results posted
2026-02-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04414306. Inclusion in this directory is not an endorsement.